Authors: Dunne, MW

Citation: Mw. Dunne, Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: The WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial, J INFEC DIS, 181, 2000, pp. S572-S578

Authors: Dunne, MW Bozzette, S McCutchan, JA Dube, MP Sattler, FR Forthal, D Kemper, CA Havlir, D

Citation: Mw. Dunne et al., Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial, LANCET, 354(9182), 1999, pp. 891-895

Authors: Koletar, SL Berry, AJ Cynamon, MH Jacobson, J Currier, JS MacGregor, RR Dunne, MW Williams, DJ

Citation: Sl. Koletar et al., Azithromycin as treatment for disseminated Mycobacterium avium complex in AIDS patients, ANTIM AG CH, 43(12), 1999, pp. 2869-2872

Authors: Havlir, DV Dube, MP McCutchan, JA Forthal, DN Kemper, CA Dunne, MW Parenti, DM Kumar, PN White, AC Witt, MD Nightingale, SD Sepkowitz, KA MacGregor, RR Cheeseman, SH

Citation: Dv. Havlir et al., Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS, CLIN INF D, 27(6), 1998, pp. 1369-1375